Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment.

Law SM, Choyce A, Barzinji H, Ellis H, Kosmidis C, Seaton RA

Open source

DOI
10.1093/jacamr/dlaf234
Published
2025 Dec
Container
JAC-antimicrobial resistance
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jacamr/dlaf234,
  title = {Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment.},
  author = {Law SM and Choyce A and Barzinji H and Ellis H and Kosmidis C and Seaton RA},
  year = {2025},
  journal = {JAC-antimicrobial resistance},
  doi = {10.1093/jacamr/dlaf234},
  url = {https://doi.org/10.1093/jacamr/dlaf234}
}

RIS

TY  - JOUR
TI  - Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment.
AU  - Law SM
AU  - Choyce A
AU  - Barzinji H
AU  - Ellis H
AU  - Kosmidis C
AU  - Seaton RA
PY  - 2025
JO  - JAC-antimicrobial resistance
DO  - 10.1093/jacamr/dlaf234
UR  - https://doi.org/10.1093/jacamr/dlaf234
ER  - 

APA

SM, L., A, C., H, B., H, E., C, K., & RA, S. (2025). Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment.. JAC-antimicrobial resistance. https://doi.org/10.1093/jacamr/dlaf234

Source records